Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Appili Therapeutics Inc (APLI.TO)

Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Appili Therapeutics Inc 1344 Summer Street Suite 21 Halifax NS B3H 0A8 CAN

https://www.appilitherapeutics.com P: 902-442-4655 F: 902-442-4651

Description:

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.

Key Statistics

Overview:

Market Capitalization, $K 4,244
Shares Outstanding, K 121,266
Annual Sales, $ 334 K
Annual Net Income, $ -9,243 K
Last Quarter Sales, $ 478 K
Last Quarter Net Income, $ -152 K
60-Month Beta 0.62
% of Institutional Shareholders 54.42%

Growth:

1-Year Return 14.29%
3-Year Return -97.20%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date 02/13/24
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -62.49%
Dividend Payout Ratio 0.00%

APLI.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -234.31%
Profit Margin % -2,765.90%
Debt/Equity N/A
Price/Sales 3.69
Price/Book N/A
Book Value/Share -0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar